White label ELPA - ClinicalTrials.eu

Study of Atomoxetine to Reduce Freezing of Gait in Patients with Parkinson’s Disease During OFF-State

Recruiting

3 1 1
Investigated Diseases:
- Parkinson’s disease
Investigated Drugs:
- Atomoxetine
Early Treatment with Argipressin (Arginine Vasopressin) in Adult Intensive Care Patients with Norepinephrine-Resistant Vasoplegic Shock

Recruiting

3 1 1
Investigated Diseases:
- Vasoplegia syndrome
Investigated Drugs:
- Argipressin
- Sodium Chloride
Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease

Recruiting

3 1
Investigated Diseases:
- Arteriosclerosis
Investigated Drugs:
- Maridebart Cafraglutide
+12
Study of fosmanogepix compared to standard antifungal drugs for treating invasive mold infections in adults

Recruiting

3 1 1 1
Investigated Drugs:
+2
Study of Debio 4126, a new octreotide formulation, compared to placebo in patients with acromegaly who were previously treated with somatostatin analogs

Recruiting

3 1 1
Investigated Diseases:
- Acromegaly
Investigated Drugs:
- Lanreotide
- Octreotide
+10
Comparing tarlatamab with standard chemotherapy in patients with pre-treated advanced pulmonary or gastroenteropancreatic neuroendocrine carcinomas

Recruiting

3 1 1 1
Investigated Diseases:
- Neuroendocrine tumour of the lung
- Gastroenteropancreatic neuroendocrine tumour disease
Investigated Drugs:
Study of BMS-986482 alone or with nivolumab, relatlimab or bevacizumab in patients with advanced solid tumors

Recruiting

2 1 1 1
Investigated Diseases:
- Neoplasm
Investigated Drugs:
+2
Study of Blinatumomab Treatment in Patients with Systemic Lupus Erythematosus, Systemic Sclerosis, or Granulomatosis with Polyangiitis: Safety and Effectiveness Evaluation

Recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
- Blinatumomab
Study of BGB-16673 in combination with drug therapy for patients with relapsed or refractory B-cell malignancies

Recruiting

1 1 1 1
Investigated Diseases:
Investigated Drugs:
Study of XL092 and belzutifan combination therapy in people with clear cell kidney cancer who had disease return during or after immunotherapy treatment

Recruiting

1 1 1
Investigated Drugs:
- Belzutifan
- N-(4-Fluorophenyl)-N-(4-((7-Methoxy-6-(Methylcarbamoyl)Quinolin-4- Yl)Oxy)Phenyl)Cyclopropane-1,1-Dicarboxamide

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies